These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5160795)

  • 1. [Toxicological and pharmacological properties of polyvinyl pyridine-N-oxide with different molecular weights].
    Shadurskiĭ KS; Dubovik BV; Il'iuchenok TIu; Shevchuk AS; Lushnikova GA
    Farmakol Toksikol; 1971; 34(4):485-9. PubMed ID: 5160795
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].
    Bogdanskaia NI
    Gig Tr Prof Zabol; 1973 May; 17(5):22-5. PubMed ID: 4771393
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antifibrous action of polyvinyl-pyridine-N-oxides in experimental silicosis].
    Bezrodnykh AA; Kasparov AA; Mazurov VI; Razvodovskiĭ EF; Kochetkova TA
    Gig Tr Prof Zabol; 1973 Dec; 17(12):20-4. PubMed ID: 4789533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
    Bogdanskaia NI; Tolgskaia MS
    Gig Sanit; 1973 Apr; 38(4):102-4. PubMed ID: 4731236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
    Deĭnega VG; Bolonova LN; Sukhanov VV; Zemliakova LF; Tkachuk SV
    Gig Tr Prof Zabol; 1977; (6):25-8. PubMed ID: 892540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detoxicating effects of poly-2-vinylpyridine-N-oxide].
    Antweiler H
    Beitr Silikoseforsch Pneumokoniose; 1970; 22(3):93-172. PubMed ID: 4325737
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
    Gel'fon IA
    Gig Tr Prof Zabol; 1978 Sep; (9):54. PubMed ID: 689462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].
    Prügger F; Mallner B; Schlipköter HW
    Wien Klin Wochenschr; 1984 Dec; 96(23):848-53. PubMed ID: 6396971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of the antisilicotic effect of polyvinylpyridine-N-oxide].
    Katsnel'son BA; Babushkina LG; Aronova GV; Starikova SK; Pochashev EN
    Gig Sanit; 1970 Oct; 35(10):20-4. PubMed ID: 5507534
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental silicosis caused by the dust from extra-pure crystalline silicon and the effect of polyvinylpyridine N-oxide on its course].
    Golodnikov IuN
    Gig Tr Prof Zabol; 1978 Dec; (12):31-6. PubMed ID: 720881
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regression of experimental silicotic granuloma under the influence of polyvinylpyridin-N-oxide].
    Grundmann E; Schlipköter HW
    Verh Dtsch Ges Pathol; 1969; 53():367-70. PubMed ID: 4191095
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
    Dubovik BV; Shadurskiĭ KS; Etlis VS; Lushnikova GA; Shevchuk AS
    Farmakol Toksikol; 1971; 34(3):352-7. PubMed ID: 5568700
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prevention of industrial pneumoconiosis].
    Brockhaus A; Dolgner R
    Zentralbl Bakteriol Orig; 1965 Dec; 198(1):133-7. PubMed ID: 5875512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on the elimination of hydroxyproline during treatment of silicosis in man with polyvinyl-pyridine-N-oxide (author's transl)].
    Schlipköter H; Grünspan M; Dehnen W; Mallner B
    Infection; 1974; 2(1):25-8. PubMed ID: 4598261
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effectiveness of polyvinoxide in silicosis and silicotuberculosis].
    Zislin DM; Gol'del'man AG; Katsnel'son BA; Tikhotskaia LI; Rassokhina TG
    Gig Tr Prof Zabol; 1985 Nov; (11):21-5. PubMed ID: 4085887
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
    Haas P; Huber W
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):91-100. PubMed ID: 5171411
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of polyvinylpyridine N-oxide on individual lung tissue indices in experimental silicosis].
    Mukhina ST; Veretinskaia AG
    Gig Tr Prof Zabol; 1974 Oct; (10):33-5. PubMed ID: 4465165
    [No Abstract]   [Full Text] [Related]  

  • 18. [Corticosteroid therapy in pneumoconiosis (author's transl)].
    Casula D
    Acta Tuberc Pneumol Belg; 1977; 68(1):87-95. PubMed ID: 930798
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advances in the study of anti-silicotic agents].
    Huang FZ; Li QL; Qu SJ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):118-21. PubMed ID: 3527609
    [No Abstract]   [Full Text] [Related]  

  • 20. Poly (2-vinylpyridine 1-oxide) in silicosis therapy: effective molecular weight.
    Hasirci VN; Holt PF
    Int Arch Occup Environ Health; 1977; 38(3):177-88. PubMed ID: 832913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.